Endomyocardial Biopsy Market Size & Share 2023 to 2032
Market Size by Product (Forceps, Accessories), by Tip (Maxi-curved, Straight, Pre-curved).
Report ID: GMI6455
|
Published Date: August 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
Endomyocardial Biopsy Market size
Endomyocardial Biopsy Market size was valued at USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032. An endomyocardial biopsy is a medical procedure used to obtain a small sample of tissue from the inner lining of the heart, known as the endocardium.
Endomyocardial Biopsy Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
This procedure is typically performed to diagnose and monitor certain heart conditions, especially those that involve inflammation, infection, rejection after heart transplantation, or other disorders that affect the heart muscle or its lining. Technological advancements in medical imaging, catheterization techniques, and biopsy tools can enhance the accuracy, safety, and efficiency of endomyocardial biopsies.
The growing prevalence of cardiovascular diseases is a major driving factor for the industry. Cardiovascular diseases, such as heart failure, cardiomyopathies, and myocarditis, continue to be a significant global health concern. For instance, as per the World Health Organization (WHO), cardiac diseases are the number one cause of death globally, accounting for an estimated 20.5 million deaths in 2021. Further, the incidence of cardiovascular diseases is increasing, partially due to factors such as sedentary lifestyle, unhealthy diet, tobacco use, obesity, and an increasing aging population base.
COVID-19 Impact
The COVID-19 pandemic initially had a negative impact on the endomyocardial biopsy market, with healthcare systems prioritizing COVID-19 cases and postponing non-urgent procedures. Fear of infection and restrictions on movement further contributed to a decline in elective medical tests such as endomyocardial biopsies. Moreover, due to lockdowns, travel restrictions, and concerns regarding potential exposure to the virus, several individuals postponed routine screenings and follow-up visits. This led to a decline in the number of procedures being performed, affecting the utilization of endomyocardial biopsy products.
Endomyocardial Biopsy Market Trends
The increasing number of heart transplants globally has led to a greater demand for endomyocardial biopsies. Endomyocardial biopsies are commonly performed after heart transplantations to monitor for rejection and other complications. An increase in the number of heart transplant surgeries contribute to the increasing demand for biopsies. According to the United Network for Organ Sharing, in 2022, nearly 42,887 organ transplants were performed in the U.S. Among these transplants, 8,409 were heart transplants.
Furthermore, the growing adoption of minimally invasive procedures in the field of cardiology has positively impacted the industry. Minimally invasive techniques are preferred by both patients and healthcare providers owing to its several advantages including smaller incisions, reduced post-operative pain, faster recovery times, shorter hospital stays, and lower risk of complications.
Endomyocardial Biopsy Market Analysis
The endomyocardial biopsy market by product is categorized into forceps and accessories. The forceps segment garnered USD 229.3 million revenue size in the year 2022. Procedures for endomyocardial biopsy (EMB) frequently involve the use of forceps. The development of new and improved forceps with better grip and precision is increasing the demand for forceps in endomyocardial biopsy procedures. Additionally, forceps are offered in a variety of sizes and shapes to accommodate the requirements of various patients and operations.
Based on tip, the endomyocardial biopsy market is segmented into maxi-curved, straight, pre-curved and others. The straight segment accounted for over 36% market share in the year 2022. The straight tip design offers precise and targeted biopsy, enhancing manoeuvrability within the heart's chambers. Its compatibility with catheters enables a minimally invasive approach, leading to faster patient recovery. Furthermore, the real-time visualization feature and adaptability to various patient anatomies make it a versatile and widely accepted choice.
Based on end-use, the endomyocardial biopsy market is segmented into hospital, ambulatory surgical centers, and others. The hospital segment accounted for over 51% market share in the year 2022. Hospitals with active heart transplant programs require regular and thorough monitoring of transplant recipients to detect early signs of rejection. Furthermore, the growing number of hospitals around the world is expected to drive industry expansion as more people gain access to healthcare services.
U.S. endomyocardial biopsy market accounted for USD 109 million revenue size in 2022. The progression is majorly attributable to rapid technological advancements in products, highly advanced, and well-established healthcare infrastructure with specialized cardiac centers and cutting-edge medical facilities. This enables the efficient and widespread adoption of endomyocardial biopsy procedures. Furthermore, the U.S. actively focuses on heart transplantation programs, driving the demand for regular endomyocardial biopsies to monitor transplant recipients.
Endomyocardial Biopsy Market Share
Some of the eminent industry participants operating in the endomyocardial biopsy market include :
Endomyocardial Biopsy Industry News:
Endomyocardial Biopsy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product (USD Million & Units)
By Tip (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →